OK, GOP - Are You Embarrassed Yet? I can’t imagine

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
257
Quote:
OK, GOP - Are You Embarrassed Yet?

I can’t imagine that you’re not totally humiliated by the Idiot you put in the White House – but then, one has to have some kind of scruples, some set of core principles that supersede all other considerations in order to feel shame – and you apparently have neither.

I had no hand in supporting Trump, and I most assuredly did not vote for him. And yet I find myself cringing every time he opens his mouth. I cannot begin to imagine the shame I would feel if I had actually contributed to his being elevated to any position of power or influence, no less the office of the presidency of the United States.

I keep wondering when you will determine that a line has been crossed, when you will decide that this foul-mouthed, totally incompetent asshole has gone too far. Sadly, it seems obvious that your party and its members are devoid of common decency, and unable to distinguish between behavior that is appropriate for a man in Trump’s position and the words and actions of a bullying schoolyard brute.

Despite your alleged good Christian values, you sat in silence as a self-declared “pussy-grabber”, with your oh-so-eager help, rose to the highest office in the land. Despite your claims that he was equipped to handle the responsibilities of that office, you sat in silence as he repeatedly demonstrated his complete ignorance of what those responsibilities entailed, along with his obvious inability to fulfill them.

Despite eight years of endless criticism of Obama – eight years of governance that actually did make America great again after the ineptitude of George W. Bush and its consequences – you cheered as a classless, clueless buffoon sat his lard-ass in the Oval Office, and immediately proclaimed his intentions to un-do everything that Obama had accomplished for the betterment of the citizenry, and the nation as a whole.

When Trump “tweeted” nonsense aimed at demeaning anyone he perceived as having crossed him, you ignored it. When he made statements that amounted to incoherent gibberish, you looked the other way.

When he repeatedly lied about everything from his electoral “win” to statistics he clearly pulled from his own behind, you twiddled your thumbs and stared off into space. When he praised Putin and disparaged our allies, you kept your fingers in your ears and your mouths firmly shut.

And now, on top of everything else this deranged idiot has already done to tarnish our nation’s standing in the world, he has accused President Barack Obama – without any evidence whatsoever – of having used illegal means to spy on him.

Exactly where do you draw the line? Precisely when do you stand up to this ridiculous excuse of a POTUS, and hang your collective heads in shame at the thought of having placed him in a position where he is free to so blatantly disrespect the office of the presidency by making such ludicrous accusations?

Your boy, Trump, has already made our country a laughingstock by virtue of the fact he could ever have attained the presidency in the first place.

While our global neighbors shake their heads in disbelief at the unreality of it all, you continue to make excuses for a lying, vengeful, self-serving prick who has no business defiling our White House, and everything it represents, with his never-ending displays of foolishness, abject stupidity, and behavior that is unbefitting a decent human being, no less the supposed leader of the free world.

Throughout the presidential campaign and now Trump’s time in office, I have awaited that moment when someone, anyone, on your side of the aisle says enough is enough, we can no longer hide behind the pretense that this madman is somehow suitable for the office of POTUS.

I have waited for that time when your embarrassment takes hold, when your humiliation is so great that you can no longer live with your own guilty conscience in having kept silent for so long.

Will that day ever come? Will you ever have the guts to muzzle the rabid dog you have unleashed on the nation, and admit your complicity in allowing it to literally shit all over everything our country stands for?

Given your silence thus far, I doubt you are capable of doing anything that requires something more than standing on the sidelines while Putin’s pooch destroys us all.

Your unwillingness to end the disaster that is this Trump "presidency" is no longer simply a matter of standing back and allowing the chips to fall where they may - it is aiding and abetting an insane criminal in his quest to reshape our country into something abhorrent to every conscientious American, and every thinking member of the global community.

You should be ashamed of yourselves, and what you have wrought. But that takes a conscience; it takes patriotism, it takes courage, and it takes decency – all qualities which you clearly lack.

It takes those whose love of freedom outweighs the idea of political victory. In other words, it takes more than lip-service to an idiot who has absolutely no concept of the duties of his office, and no regard for the well-being of people he pretends to lead.

At least we now know where you stand - at the back of the room, cowering in silence and completely uncaring about your country, your fellow citizens, and your commitment to the furtherance of our democracy.

Your lack of embarrassment says it all. You, the GOP, are devoid of principles. I can only hope that the citizenry remembers your cowardice in the days to come, and vote accordingly in future - and I have a feeling that they will do exactly that.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 468

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 514

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 527

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 350

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 479

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 292

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 354

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 631

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 90

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 122

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading

Top 5 Most Recently Viewed Articles

Zenarate Achieves Remarkable Growth, Securing Top Technology Honors

Updated Category News Views 231

Zenarate's Impressive Achievement in the Fast-Growing Tech Sector Zenarate, a leading platform focused on enhancing human and AI agent performance, has made waves in the tech industry with its exceptional ranking. With a remarkable growth of 496%, Zenarate has earned the prestigious recognition as the 165th fastest-growing company on the Deloitte Technology Fast 500™...

Continue Reading
GitLab Inc. Investors Encouraged to Participate in Class Action

Updated Category News Views 64

Important Class Action Opportunity for GitLab Inc. Investors GitLab Inc. shareholders are facing a critical moment, with a significant class action opportunity emerging due to recent events. Robbins Geller Rudman & Dowd LLP has made a vital announcement urging investors who bought GitLab securities during specific dates to come forward. This class action lawsuit, known as...

Continue Reading
Transforming $1000 into Significant Wealth with EME Investment

Updated Category News Views 261

Transform Your Investment Journey with EMCOR Group Investing wisely is a journey that can lead to fruitful rewards, especially when considering the historical performance of a stock. EMCOR Group (EME) is a fine example, having shown impressive growth over the past 15 years. If one were to invest $1000 in EME back then, they would be pleasantly surprised by today's...

Continue Reading
Brown & Brown, Inc. Declares Regular Quarterly Dividend Payment

Updated Category News Views 199

Brown & Brown, Inc. Dividends: Commitment to Shareholders Brown & Brown, Inc. (NYSE: BRO), an established insurance brokerage firm, recently made headlines with the announcement of a quarterly cash dividend of $0.15 per share. This decision was made public by the company's board of directors, illustrating their ongoing commitment to delivering value to their shareholders....

Continue Reading
OCS Finalizes Landmark Acquisition of EMCOR UK for Growth

Updated Category News Views 251

OCS Completes Acquisition of EMCOR UK OCS has officially completed its acquisition of EMCOR UK, marking a significant milestone in the facilities management sector. This strategic move follows the rigorous UK regulatory process, enabling OCS to merge with one of the largest hard services-led businesses in the region. The integration is expected to leverage the extensive...

Continue Reading